Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Short-Term Debt issuances (2016 - 2022)

Prestige Consumer Healthcare (PBH) has 9 years of Short-Term Debt issuances data on record, last reported at $20.0 million in Q2 2022.

  • For Q2 2022, Short-Term Debt issuances fell 76.47% year-over-year to $20.0 million; the TTM value through Mar 2023 reached $20.0 million, down 76.47%, while the annual FY2023 figure was $20.0 million, 76.47% down from the prior year.
  • Short-Term Debt issuances reached $20.0 million in Q2 2022 per PBH's latest filing, down from $85.0 million in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $85.0 million in Q2 2021 and bottomed at $10.0 million in Q1 2018.
  • Average Short-Term Debt issuances over 5 years is $25.0 million, with a median of $15.0 million recorded in 2018.
  • Peak YoY movement for Short-Term Debt issuances: tumbled 88.89% in 2018, then skyrocketed 50.0% in 2019.
  • A 5-year view of Short-Term Debt issuances shows it stood at $15.0 million in 2018, then changed by 0.0% to $15.0 million in 2019, then changed by 0.0% to $15.0 million in 2020, then soared by 466.67% to $85.0 million in 2021, then plummeted by 76.47% to $20.0 million in 2022.
  • Per Business Quant database, its latest 3 readings for Short-Term Debt issuances were $20.0 million in Q2 2022, $85.0 million in Q2 2021, and $15.0 million in Q4 2020.